Unravelling the molecular basis for cardiac iron metabolism and deficiency in heart failure.

about

TIMP3 deficiency exacerbates iron-overload mediated cardiomyopathy and liver disease.Iron deficiency impairs contractility of human cardiomyocytes through decreased mitochondrial function.

P2860

Q49663340-607E6649-2CEC-4989-819F-EF3505EEF885 Q55259995-525E5C85-E72C-489F-B7F0-2F972F4DB313

P2860

Unravelling the molecular basis for cardiac iron metabolism and deficiency in heart failure.

Item

http://www.wikidata.org/entity/Q54357583

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Unravelling the molecular basi ...... d deficiency in heart failure.

@en

Unravelling the molecular basi ...... d deficiency in heart failure.

@nl

type

Item

label

Unravelling the molecular basi ...... d deficiency in heart failure.

@en

Unravelling the molecular basi ...... d deficiency in heart failure.

@nl

prefLabel

Unravelling the molecular basi ...... d deficiency in heart failure.

@en

Unravelling the molecular basi ...... d deficiency in heart failure.

@nl

P1476

Unravelling the molecular basi ...... d deficiency in heart failure.

@en

P2093

Gavin Y Oudit

http://www.w3.org/2001/XMLSchema#string

Pavel Zhabyeyev

http://www.w3.org/2001/XMLSchema#string

P2860

Disorders of iron metabolism

The failing heart--an engine out of fuel

Balancing acts: molecular control of mammalian iron metabolism

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribut

Cardiac ferroportin regulates cellular iron homeostasis and is important for cardiac function.

Iron-overload injury and cardiomyopathy in acquired and genetic models is attenuated by resveratrol therapy.

Role of L-type Ca2+ channels in iron transport and iron-overload cardiomyopathy.

Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives.

Iron status in patients with chronic heart failure.

CONSENSUS to EMPHASIS: the overwhelming evidence which makes blockade of the renin-angiotensin-aldosterone system the cornerstone of therapy for systolic heart failure.

P304

373-375

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1093/EURHEARTJ/EHW386

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27651442

http://www.w3.org/2001/XMLSchema#string

P921

heart failure

P932

5837428

http://www.w3.org/2001/XMLSchema#string

Unravelling the molecular basis for cardiac iron metabolism and deficiency in heart failure.

about

P2860

P2860

Unravelling the molecular basis for cardiac iron metabolism and deficiency in heart failure.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932